Table 2

Measures of hemolysis and inflammation in PHT and stroke

Variable*PHT (n = 20)No PHT (n = 54)PStroke (n = 11)No stroke (n = 62)P
Hb level, g/dL 7.6 (6.3-8.8) 9.4 (8.3-10.2) < .001 7.5 (6.9-9.4) 9 (7.8-10.2) .03 
LDH level, U/L 1077 (879-1364) 808 (620-1079) .03 1136 (947-1367) 840 (646-1123) .05 
sVCAM level, ng/mL 1123 (758-1346) 624 (486-947) < .001 1135 (813-1563) 753 (515-1044) .05 
PlGF level, pg/mL 11.5 (8.8-15.4) 8.5 (5.7-10.8) .009 11.0 (8.4-16.0) 8.8 (6.0.-11.3) .08 
Variable*PHT (n = 20)No PHT (n = 54)PStroke (n = 11)No stroke (n = 62)P
Hb level, g/dL 7.6 (6.3-8.8) 9.4 (8.3-10.2) < .001 7.5 (6.9-9.4) 9 (7.8-10.2) .03 
LDH level, U/L 1077 (879-1364) 808 (620-1079) .03 1136 (947-1367) 840 (646-1123) .05 
sVCAM level, ng/mL 1123 (758-1346) 624 (486-947) < .001 1135 (813-1563) 753 (515-1044) .05 
PlGF level, pg/mL 11.5 (8.8-15.4) 8.5 (5.7-10.8) .009 11.0 (8.4-16.0) 8.8 (6.0.-11.3) .08 

PHT indicates pulmonary hypertension; Hb, hemoglobin; LDH, lactate dehydrogenase; sVCAM, soluble vascular cell adhesion molecule-1; and PlGF, placenta growth factor.

*

Data are presented as medians and interquartile ranges (25th-75th percentiles).

or Create an Account

Close Modal
Close Modal